Search

Inhibition of TNF-α improves the bladder dysfunction that is associated with type 2 diabetes

Publication: Bill

Wang, Z., Z. Cheng, V. Cristofaro, J. Li, X. Xiao, P. Gomez, R. Ge, et al. 2012. Inhibition of TNF-α Improves the Bladder Dysfunction That Is Associated With Type 2 Diabetes.

Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism

Publication: Bill

Fendt, S. M., E. L. Bell, M. A. Keibler, S. M. Davidson, G. J. Wirth, B. Fiske, J. R. Mayers, et al. 2013. Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism.

Case records of the Massachusetts General Hospital. Case 25-2013. A 71-year-old man with hematuria and a mass in the bladder

Publication: Bill

Olumi, A. F., D. S. Kaufman, A. Zietman, M. G. Harisinghani, and C. L. Wu. 2013. Case Records of the Massachusetts General Hospital. Case 25-2013. A 71-Year-Old Man With Hematuria and a Mass in the Bladder.

Search

Search results

Inhibition of TNF-α improves the bladder dysfunction that is associated with type 2 diabetes

Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism

Case records of the Massachusetts General Hospital. Case 25-2013. A 71-year-old man with hematuria and a mass in the bladder

Medical oncology consultation and minimization of overtreatment in men with low-risk prostate cancer

Metformin use and prostate cancer risk

Clinical features of leiomyosarcoma of the urinary bladder: analysis of 183 cases

Prostate cancer in transgender women

Metformin: an antiproliferative agent and methylation regulator in treating prostatic disease?

Expression of aromatase in tumor related stroma is associated with human bladder cancer progression

BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions